Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study

(1) Background: Glucagone-Like Peptide-1 Receptor Agonists (GLP-1 RAs) (GLP-1 RAs) are incretine-based medications recommended in the treatment of type 2 Diabetes Mellitus (DM2) with atherosclerotic cardiovascular disease (ASCVD) or high or very high cardiovascular (CV) risk. However, knowledge of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Paolo, Guaricci, Andrea Igoren, Piazzolla, Giuseppina, Volpe, Sara, Vozza, Alfredo, Benedetto, Marina, Carella, Maria Cristina, Santoro, Daniela, Monitillo, Francesco, Baggiano, Andrea, Mushtaq, Saima, Fusini, Laura, Fazzari, Fabio, Forleo, Cinzia, Ribecco, Nunziata, Pontone, Gianluca, Sabbà, Carlo, Ciccone, Marco Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962489/
https://www.ncbi.nlm.nih.gov/pubmed/36836121
http://dx.doi.org/10.3390/jcm12041586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962489/
https://www.ncbi.nlm.nih.gov/pubmed/36836121
http://dx.doi.org/10.3390/jcm12041586

Ejemplares similares